C31H28F5N3O5
Neat
617.57
O-Demethyl elagolix; 832720-51-1; UNII-B3LWK12L14; B3LWK12L14; Elagolix metabolite M3 (O-demethyl metabolite); Elagolix metabolite a-1323217(O-demethyl metabolite); Elagolix metabolite NBI-61962 (O-demethyl metabolite); (R-(+)-4-(2-(5-(2-Fluoro-3-hydroxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2, 6-dioxo-3, 6-dihydro-2H-pyrimidin-1-yl)-1-phenyl-ethylamino)-butyrate); 4-[[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2, 6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid; Butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-hydroxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3, 6-dihydro-4-methyl-2, 6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-; SCHEMBL22373670; (R)-4-((2-(5-(2-fluoro-3-hydroxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2, 6-dioxo-3 and 6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid
4-[[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2 and 6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid
InChI=1S/C31H28F5N3O5/c1-18-27(20-10-5-13-25(40)28(20)33)29(43)39(17-24(19-8-3-2-4-9-19)37-15-7-14-26(41)42)30(44)38(18)16-21-22(31(34,35)36)11-6-12-23(21)32/h2-6,8-13,24,37,40H,7,14-17H2,1H3,(H,41,42)/t24-/m0/s1